ATAI | Investor Presentation Deck | 36 slides

atai Life Sciences · 2022-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

36
every slide · same image gating as the playbook
01
Slide 1
The slide uses a high-contrast portrait to evoke emotional resonance with the mission.front_matter
02
Includes a specific date note at the bottom: September 9th, 2022.other
03
The slide uses a numbered list to present five key pillars of the company's current status.summarize
04
The slide uses a combination of headshots for the team and a metric-based footer to establish credibility.summarize
Open slide detailBeat · Team
05
The slide uses a hierarchical structure to connect a high-level objective to three distinct operational pillars.present_solution
Open slide detailBeat · Solution
06
The slide uses a Gantt-style visualization to represent clinical trial progress for multiple drug candidates.plan_implementation
07
The slide uses a hub-and-spoke diagram to represent the platform model.present_solution
08
The slide uses a split-view layout: a list of past achievements on the left and a timeline of future events on the right.plan_implementation
Open slide detailLoop · Why Now
09
summarize
Open slide detailLoop · Why Now
10
transition
11
The slide uses a split layout: left side defines the condition and market size, right side outlines the 'Urgent Need for Innovation' using a process-like list oframe_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
12
Includes clinical trial data visualization and product summary table.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
13
The slide uses a dark sidebar for product specs and a white main area for clinical data visualization.summarize
14
The slide uses a split-layout with a dark sidebar for key facts and a white main area for clinical data visualization.summarize
15
Includes chemical structure diagrams and multiple bar charts showing dose-response relationships.compare_peers
16
The chart uses a dot plot to show individual patient CADSS scores over time across three cohorts (30mg, 60mg, Placebo).show_traction
17
The slide uses a timeline diagram to illustrate the clinical trial flow and two boxes to detail study design and operational status.plan_implementation
18
The slide uses a matrix-style comparison table to highlight competitive advantages.compare_peers
19
transition
20
The slide uses a split-layout: left side defines the condition and global burden, right side details the 'huge need for development' using a vertical timeline-lframe_problem
21
The slide uses a vertical timeline/process flow to show the progression of clinical development alongside key de-risking milestones.present_solution
22
Includes a quote from Keith Nuechterlein and a detailed clinical trial timeline.summarize
23
The slide highlights efficacy in cognitive endpoints for a specific patient population (DPNP).show_traction
24
CIAS likely refers to Cognitive Impairment Associated with Schizophrenia.show_traction
25
The slide uses a checkmark system to highlight specific advantages of RL-007 and a few competitors.compare_peers
26
transition
27
The slide uses a split-layout: left side provides market context and statistics, right side outlines the 'unaddressed need' framework.size_opportunity
Open slide detailBeat · Market Sizing
28
Includes a sidebar summary and a clinical trial design overview.summarize
29
The slide uses a checkmark matrix to highlight the competitive advantage of the company's drug candidate.compare_peers
30
transition
31
Uses a combination of a map, metric callouts, and a vertical process-style list to convey urgency.size_opportunity
32
Includes a summary table on the left and clinical trial data/roadmap on the right.summarize
33
The table highlights DMX-1002's unique profile compared to withdrawal support and maintenance therapies.compare_peers
34
transition
35
The slide uses a card-based layout to detail the value proposition and operational structure of four distinct entities.present_solution
36
The slide uses a personal narrative to establish the 'why' behind the company's mission.inspire_vision